{"id":"inahled-isoflurane","safety":{"commonSideEffects":[{"rate":null,"effect":"Postoperative nausea and vomiting"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Hepatotoxicity (rare)"}]},"_chembl":{"chemblId":"CHEMBL1256","moleculeType":"Small molecule","molecularWeight":"184.49"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Isoflurane potentiates GABA-A receptor activity and inhibits NMDA glutamate receptors, leading to depression of the central nervous system. This results in loss of consciousness, analgesia, and muscle relaxation suitable for surgical anesthesia. The drug is administered via inhalation and has a rapid onset and offset due to its volatile nature.","oneSentence":"Inhaled isoflurane is a volatile anesthetic that enhances inhibitory neurotransmission and suppresses excitatory signaling in the central nervous system to produce anesthesia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:15:48.113Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"General anesthesia for surgical procedures"},{"name":"Maintenance of anesthesia during surgery"}]},"trialDetails":[{"nctId":"NCT07099014","phase":"PHASE3","title":"Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09-15","conditions":"Cardiogenic Shock, ECMO","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14636,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Inahled Isoflurane","genericName":"Inahled Isoflurane","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Inhaled isoflurane is a volatile anesthetic that enhances inhibitory neurotransmission and suppresses excitatory signaling in the central nervous system to produce anesthesia. Used for General anesthesia for surgical procedures, Maintenance of anesthesia during surgery.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}